各向异性超导体的能隙函数与能隙方程

利用格林函数,推导出各向异性超导体的能隙函数的表达方程式.其过程和结果均表明,利用格林函数推导出来的各向异性超导体的能隙函数,比利用Bogoliubov正则变换来的简便.     

湍流多尺度相干结构间歇性的PIV实验研究

利用粒子成像测速(PIV)系统测量了湍流边界层中流向速度平面,并对湍流多尺度相干结构统计特性进行了实验研究.利用连续子波变换,计算了不同尺度、不同法向位置的子波系数概率密度函数.结果发现缓冲区有着更强的间歇性.利用子波系数量化湍流间歇性的方法,应用推广的自相似律(ESS),计算了子波系数结构函数的标度指数.研究表明:当多尺度相干结构被提取出后,利用子波系数计算的ESS标度律就符合科尔莫戈罗夫提出的线性标度律,验证了多尺度相干结构是湍流边界层产生奇异标度律的原因.此外,利用PIV系统测量的数据,给出了流向平面内的以子波系数表达的能量分布.这种方法有利于进一步对多尺度相干结构在空间平面内的辨识与特性进行研究.     

一类低相关序列

给出一类d型函数,用该函数构造出了一类低相关序列集.这类序列集的周期为2n-1,集合中序列的条数为2n,其中n=4m 2.证明了其非平凡相关值只取以下4个值{-1,±2n/2-1,2n/2 1-1}.     

Lidstone边值问题多个单调正解的存在性

对含有各阶导数的2m阶微分方程:y(2m)(t)=f(t,y(t),y′(t),…,y(2m-2)(t),y(2m-1)(t)),t∈(0,1),y(2i+1)(0)=y(2i)(1)=0,0≤i≤m-1,其中(-1)mf:[0,1]×R2m→[0,∞)是连续的。笔者首先给出方程的Green函数及其一些性质,并赋予f一定的增长条件,利用5个泛函的不动点定理,然后给出上述边值问题的3个单调正解的存在性。     

弦振泛频分析及演奏中的泛音

根据弦振驻波的规律,证明了弦乐器振动中各次振动的振幅递减之规律,给出了演奏中准确的泛音触弦位置,揭示了拉弦类乐器泛音的物理本质,是设计扩展音域、增加自然泛音的理论根据。     

存储过程在管理信息系统开发中的应用

存储过程是一种重要的数据库对象,恰当地使用存储过程可以简化应用程序的开发,增强管理信息系统的灵活性及安全性.     

用MATLAB求解Butterworth最优传递函数

采用MATLAB语言编写函数bwden,通过主程序调用该函数可求出任意阶Butterworth最优传递函数分母多项式的系数,绘制出Butterworth最优传递函数的极点分布图,阶跃响应曲线及波德图.8阶Butter-worth最优传递函数的求解和仿真表明,可有效且简便地用MATLAB求解Butterworth最优传递函数.     

DNA methylation of fly genes and transposons

The use of anti-5-methylcytosine antibodies in affinity columns allowed the identification of methylated sequences in the genome of Drosophila melanogaster adults. In view of the presence of transposable elements amongst the identified sequences, it has been suggested that DNA methylation is involved in transposon control in the fly genome. On the contrary, a reanalysis of these data furnishes several intriguing elements that could raise new questions about the role that DNA methylation plays in the fly genome. The aim of the present paper is to discuss some features that emerge from the analysis of the identified methylated sequences. Received 26 January 2006; received after revision 8 May 2006; accepted 2 June 2006     

Betaine homocysteine S-methyltransferase: just a regulator of homocysteine metabolism?

Betaine homocysteine methyltransferase (BHMT), a Zn²⁺-dependent thiolmethyltransferase, contributes to the regulation of homocysteine levels, increases in which are considered a risk factor for cardiovascular diseases. Most plasma homocysteine is generated through the liver methionine cycle, in which BHMT metabolizes approximately 25% of this non-protein amino acid. This process allows recovery of one of the three methylation equivalents used in phosphatidylcholine synthesis through transmethylation, a major homocysteine-producing pathway. Although BHMT has been known for over 40 years, the difficulties encountered in its isolation precluded detailed studies until very recently. Thus, the last 10 years, since the sequence became available, have yielded extensive structural and functional data. Moreover, recent findings offer clues for potential new functions for BHMT. The purpose of this review is to provide an integrated view of the knowledge available on BHMT, and to analyze its putative roles in other processes through interactions uncover to date. Received 26 May 2006; received after revision 3 July 2006; accepted 24 August 2006     

Lipid-lowering drugs

Although a change in life-style is often the method of first choice for lipid lowering, lipid-lowering drugs, in general, help to control elevated levels of different forms of lipids in patients with hyperlipidemia. While one group of drugs, statins, lowers cholesterol, the other group, fibrates, is known to take care of fatty acids and triglycerides. In addition, other drugs, such as ezetimibe, colesevelam, torcetrapib, avasimibe, implitapide, and niacin are also being considered to manage hyperlipidemia. As lipids are very critical for cardiovascular diseases, these drugs reduce fatal and nonfatal cardiovascular abnormalities in the general population. However, a number of recent studies indicate that apart from their lipidlowering activities, statins and fibrates exhibit multiple functions to modulate intracellular signaling pathways, inhibit inflammation, suppress the production of reactive oxygen species, and modulate T cell activity. Therefore, nowadays, these drugs are being considered as possible therapeutics for several forms of human disorders including cancer, autoimmunity, inflammation, and neurodegeneration. Here I discuss these applications in the light of newly discovered modes of action of these drugs. Received 5 September 2005; received after revision 29 December 2005; accepted 26 January 2006